Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the 'old' therapies?
Vitamin d and multiple sclerosis.
Acute disseminated encephalomyelitis (ADEM) following a H3N3 parainfluenza virus infection in a pregnant asthmatic woman with respiratory failure.
Validation survey of the impact of urinary incontinence (IIQ-7) and inventory of distress urogenital (UDI-6) - the short scales - in patients with multiple sclerosis.
Does Disease-Irrelevant Intrathecal Synthesis in Multiple Sclerosis Make Sense in the Light of Tertiary Lymphoid Organs?
The impact of the human genome project on complex disease.
Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.
Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.
Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.
Treatment with interferon beta for multiple sclerosis.
Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.
Predicting short-term conversion from CIS to MS: Relevance of lesion distribution.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
[Retinal vasculitis as manifestation of multiple sclerosis.]
Bacillus thuringiensis poisoning related acute transverse myelitis.
Efficacy of fingolimod is superior to injectable disease modifying therapies in second-line therapy of relapsing remitting multiple sclerosis.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model.
Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains.
The harm of ham hocks: Foreign body impaction in long-standing multiple sclerosis.
MicroRNA regulation of lymphocyte tolerance and autoimmunity.
Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.
Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.
Pages
« first
‹ previous
…
304
305
306
307
308
309
310
311
312
…
next ›
last »